Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial toxins are potent virulence factors produced by microorganisms, categorized into endotoxins and exotoxins. Endotoxins, primarily lipopolysaccharides (LPS), are structural components of the outer membrane of Gram-negative bacteria that are released upon bacterial cell death or lysis, triggering intense inflammatory responses via the Toll-like receptor 4 (TLR4) pathway (StatPearls, 2023; PubChem, 2024). In contrast, exotoxins are highly specific proteins secreted by both Gram-positive and Gram-negative bacteria that can cause damage to the host by destroying cells or disrupting normal cellular metabolism (Wikipedia, 2024). These toxins are responsible for the clinical manifestations of diseases such as sepsis, tetanus, botulism, and diphtheria (NIH, 2022). Therapeutic strategies focus on neutralizing these toxins using monoclonal antibodies, antitoxins, or specific binding agents like Polymyxin B to prevent systemic toxicity and organ failure (PubMed, 2021). While 'Endotoxins and exotoxins' is a broad category rather than a single molecular target, individual toxins within these groups are critical focal points for drug development and clinical management of severe infections.
Neutralization of toxin activity by binding to the toxin molecule, preventing its interaction with host cell receptors or membranes, or facilitating its clearance from circulation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial toxins (Endotoxins and Exotoxins).